Skip to main content

Keryx Biopharmaceuticals (NASDAQ: KERX) Investor Securities Class Action Lawsuit 02/01/2013

  • If you purchased shares of Company Name Inc (XXXX: XXX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 24, 2014 - The court ordered the case closed. February 14, 2014 - The court granted the defendants' motion to dismiss. August 26, 2013 - A motion to dismiss the amended consolidated complaint was filed. July 10, 2013 - An amended consolidated complaint was filed. March 11, 2013 - An amended complaint was filed. February 1, 2013 - An investor in shares of Keryx Biopharmaceutic...



You must register (for free) or login to view the entire case.